SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 157 filers reported holding SERES THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $435,000 | +131.4% | 67,770 | +23.9% | 0.00% | +100.0% |
| Q2 2022 | $188,000 | -72.1% | 54,714 | -42.1% | 0.00% | -71.4% |
| Q1 2022 | $673,000 | -24.0% | 94,574 | -11.0% | 0.01% | -30.0% |
| Q4 2021 | $885,000 | +13.2% | 106,289 | -5.4% | 0.01% | +25.0% |
| Q3 2021 | $782,000 | -72.7% | 112,414 | -6.3% | 0.01% | -68.0% |
| Q2 2021 | $2,861,000 | -16.1% | 119,951 | -27.6% | 0.02% | -24.2% |
| Q1 2021 | $3,410,000 | -7.3% | 165,626 | +10.3% | 0.03% | -19.5% |
| Q4 2020 | $3,680,000 | +822.3% | 150,203 | +176.3% | 0.04% | +1266.7% |
| Q1 2018 | $399,000 | -12.3% | 54,359 | +21.0% | 0.00% | 0.0% |
| Q4 2017 | $455,000 | -28.9% | 44,911 | +12.6% | 0.00% | -40.0% |
| Q3 2017 | $640,000 | +55.3% | 39,898 | +9.4% | 0.01% | +66.7% |
| Q2 2017 | $412,000 | +5.4% | 36,457 | +5.0% | 0.00% | 0.0% |
| Q1 2017 | $391,000 | +1.8% | 34,718 | -10.5% | 0.00% | 0.0% |
| Q4 2016 | $384,000 | -39.1% | 38,782 | -24.5% | 0.00% | -40.0% |
| Q3 2016 | $631,000 | -60.9% | 51,344 | -7.5% | 0.01% | -64.3% |
| Q2 2016 | $1,613,000 | – | 55,517 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
| Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
| Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
| Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
| Knott David M Jr | 470,000 | $2,251 | 0.90% |
| GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
| Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
| Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
| Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
| Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |